stockrow
Friday 6 November 2026
Export NMTC’s income statement to Excel — free account
NeuroOne Medical Technologies Corporation
NMTC Healthcare Medical Devices
NeuroOne Medical Technologies Corporation’s revenue for fiscal 2025 (year ended September 2025) was $9.1 million, up 163.5% from fiscal 2024.
- Revenue
- +16.3%
- EPS
- −27.8%
- Free cash flow
- +26.9%
Quarter to June 2026, against a year earlier
0.85
0.01
−1.16%
Follow NMTC
Alert me
NeuroOne Medical Technologies Corporation (NMTC) P/E ratio
NeuroOne Medical Technologies Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 20 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BTCY Biotricity Inc. compare | n/m |
| INBS Intelligent Bio Solutions Inc. compare | n/m |
| SINT SINTX TECHNOLOGIES, INC. compare | n/m |
| NMTC NeuroOne Medical Technologies Corporation | n/m |
| VNRX VolitionRX Limited compare | n/m |
| TBIO Telesis Bio Inc. compare | n/m |
| AEMD Aethlon Medical, Inc. compare | n/m |
| BMRA Biomerica, Inc. compare | n/m |
| IRIX IRIDEX Corporation compare | n/m |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)